Orlistat Pellets Manufacturer & Supplier
Lipase-inhibiting pellets created for weight management therapies, formulated to minimise oily spotting and maintain potency.
Product overview
Orlistat is a gastrointestinal lipase inhibitor used in weight-management formulations. Rraynex pellet technology focuses on controlled drug distribution, particle-size consistency, moisture management, and physical integrity to support downstream pharmaceutical processing. The pelletized format is suitable for capsule-based and multiparticulate dosage-form development where reproducibility and processability are important.
Key characteristics
- Controlled active distribution across the pellet matrix.
- Smooth flow characteristics for downstream capsule filling.
- Controlled moisture and drying conditions.
- Suitable for development and commercial pharmaceutical manufacturing.
- Technical support for capsule filling, excipient compatibility, and formulation optimization.
Product specifications
- Product
- Orlistat Pellets
- Form
- Pellets
- Therapeutic category
- Anti-Obesity
- Strength
- 50%
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Orlistat Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities
Other Orlistat products from Rraynex
- Orlistat (WW) — Pellets